Listed

Utah Medical Products Inc

UTMDNasdaqCIK 706698HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$8.5m, Q2 FY2026
Operating income$2.6m, Q2 FY2026
Net income$2.7m, Q2 FY2026
Utah Medical Products Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m12.5Revenue, Q3 FY2023, three months to 2023-09-30$12.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure12.3Revenue, Q4 FY2023, three months to 2023-12-31$12.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure11.3Revenue, Q1 FY2024, three months to 2024-03-31$11.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure10.4Revenue, Q2 FY2024, three months to 2024-06-30$10.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure10.0Revenue, Q3 FY2024, three months to 2024-09-30$10.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure9.2Revenue, Q4 FY2024, three months to 2024-12-31$9.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure9.7Revenue, Q1 FY2025, three months to 2025-03-31$9.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure10.0Revenue, Q2 FY2025, three months to 2025-06-30$10.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure9.8Revenue, Q3 FY2025, three months to 2025-09-30$9.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure9.0Revenue, Q4 FY2025, three months to 2025-12-31$9.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure8.7Revenue, Q1 FY2026, three months to 2026-03-31$8.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure8.5Revenue, Q2 FY2026, three months to 2026-06-30$8.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure
Cost of revenue$m5.1Cost of revenue, Q3 FY2023, three months to 2023-09-30$5.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-12, accession 0001811884-24-000022.Report this figure5.2Cost of revenue, Q4 FY2023, three months to 2023-12-31$5.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure4.6Cost of revenue, Q1 FY2024, three months to 2024-03-31$4.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure4.1Cost of revenue, Q2 FY2024, three months to 2024-06-30$4.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-12, accession 0001096906-25-001281.Report this figure4.2Cost of revenue, Q3 FY2024, three months to 2024-09-30$4.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figure3.8Cost of revenue, Q4 FY2024, three months to 2024-12-31$3.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure4.2Cost of revenue, Q1 FY2025, three months to 2025-03-31$4.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure4.4Cost of revenue, Q2 FY2025, three months to 2025-06-30$4.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure4.2Cost of revenue, Q3 FY2025, three months to 2025-09-30$4.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figure3.8Cost of revenue, Q4 FY2025, three months to 2025-12-31$3.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure3.4Cost of revenue, Q1 FY2026, three months to 2026-03-31$3.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure3.8Cost of revenue, Q2 FY2026, three months to 2026-06-30$3.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure
Gross profit$m7.4Gross profit, Q3 FY2023, three months to 2023-09-30$7.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure7.1Gross profit, Q4 FY2023, three months to 2023-12-31$7.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure6.8Gross profit, Q1 FY2024, three months to 2024-03-31$6.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure6.3Gross profit, Q2 FY2024, three months to 2024-06-30$6.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure5.8Gross profit, Q3 FY2024, three months to 2024-09-30$5.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure5.3Gross profit, Q4 FY2024, three months to 2024-12-31$5.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure5.5Gross profit, Q1 FY2025, three months to 2025-03-31$5.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure5.6Gross profit, Q2 FY2025, three months to 2025-06-30$5.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure5.6Gross profit, Q3 FY2025, three months to 2025-09-30$5.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure5.3Gross profit, Q4 FY2025, three months to 2025-12-31$5.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure5.3Gross profit, Q1 FY2026, three months to 2026-03-31$5.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure4.8Gross profit, Q2 FY2026, three months to 2026-06-30$4.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure
Research and development$m0.1Research and development, Q3 FY2023, three months to 2023-09-30$138.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001811884-24-000022.Report this figure0.1Research and development, Q4 FY2023, three months to 2023-12-31$146.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure0.3Research and development, Q1 FY2024, three months to 2024-03-31$266.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure0.3Research and development, Q2 FY2024, three months to 2024-06-30$255.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001096906-25-001281.Report this figure0.2Research and development, Q3 FY2024, three months to 2024-09-30$172.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figure0.1Research and development, Q4 FY2024, three months to 2024-12-31$121.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure0.2Research and development, Q1 FY2025, three months to 2025-03-31$154.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure0.1Research and development, Q2 FY2025, three months to 2025-06-30$135.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure0.2Research and development, Q3 FY2025, three months to 2025-09-30$167.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figure0.2Research and development, Q4 FY2025, three months to 2025-12-31$212.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure0.2Research and development, Q1 FY2026, three months to 2026-03-31$154.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure0.2Research and development, Q2 FY2026, three months to 2026-06-30$154.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure
Selling, general and administrative$m3.3Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$3.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0001811884-24-000022.Report this figurenot reported2.6Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$2.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure2.6Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$2.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-12, accession 0001096906-25-001281.Report this figure2.3Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$2.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figurenot reported2.2Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure2.3Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$2.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure2.8Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$2.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figurenot reported2.6Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$2.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure2.0Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$2.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure
Operating income$m4.0Operating income, Q3 FY2023, three months to 2023-09-30$4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001811884-24-000022.Report this figure3.9Operating income, Q4 FY2023, three months to 2023-12-31$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure3.9Operating income, Q1 FY2024, three months to 2024-03-31$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure3.4Operating income, Q2 FY2024, three months to 2024-06-30$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001096906-25-001281.Report this figure3.3Operating income, Q3 FY2024, three months to 2024-09-30$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figure2.9Operating income, Q4 FY2024, three months to 2024-12-31$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure3.2Operating income, Q1 FY2025, three months to 2025-03-31$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure3.2Operating income, Q2 FY2025, three months to 2025-06-30$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure2.6Operating income, Q3 FY2025, three months to 2025-09-30$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figure2.4Operating income, Q4 FY2025, three months to 2025-12-31$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure2.6Operating income, Q1 FY2026, three months to 2026-03-31$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure2.6Operating income, Q2 FY2026, three months to 2026-06-30$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure
Income tax$m0.8Income tax, Q3 FY2023, three months to 2023-09-30$846.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001811884-24-000022.Report this figure0.7Income tax, Q4 FY2023, three months to 2023-12-31$731.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure0.8Income tax, Q1 FY2024, three months to 2024-03-31$842.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure0.8Income tax, Q2 FY2024, three months to 2024-06-30$758.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001096906-25-001281.Report this figure0.6Income tax, Q3 FY2024, three months to 2024-09-30$616.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figure0.7Income tax, Q4 FY2024, three months to 2024-12-31$712.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure0.8Income tax, Q1 FY2025, three months to 2025-03-31$817.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure0.8Income tax, Q2 FY2025, three months to 2025-06-30$788.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure0.7Income tax, Q3 FY2025, three months to 2025-09-30$678.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figure0.5Income tax, Q4 FY2025, three months to 2025-12-31$540.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure0.6Income tax, Q1 FY2026, three months to 2026-03-31$578.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure0.6Income tax, Q2 FY2026, three months to 2026-06-30$600.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure
Net income$m3.9Net income, Q3 FY2023, three months to 2023-09-30$3.9m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure4.3Net income, Q4 FY2023, three months to 2023-12-31$4.3m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure4.0Net income, Q1 FY2024, three months to 2024-03-31$4.0m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure3.5Net income, Q2 FY2024, three months to 2024-06-30$3.5m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure3.6Net income, Q3 FY2024, three months to 2024-09-30$3.6m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure2.9Net income, Q4 FY2024, three months to 2024-12-31$2.9m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure3.0Net income, Q1 FY2025, three months to 2025-03-31$3.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure3.0Net income, Q2 FY2025, three months to 2025-06-30$3.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure2.6Net income, Q3 FY2025, three months to 2025-09-30$2.6m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure2.6Net income, Q4 FY2025, three months to 2025-12-31$2.6m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure2.6Net income, Q1 FY2026, three months to 2026-03-31$2.6m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure2.7Net income, Q2 FY2026, three months to 2026-06-30$2.7m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure
Diluted EPS$ per share1.08Diluted EPS, Q3 FY2023, three months to 2023-09-30$1.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure1.18Diluted EPS, Q4 FY2023, three months to 2023-12-31$1.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure1.09Diluted EPS, Q1 FY2024, three months to 2024-03-31$1.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure0.98Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure1.03Diluted EPS, Q3 FY2024, three months to 2024-09-30$1.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure0.86Diluted EPS, Q4 FY2024, three months to 2024-12-31$0.86 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure0.92Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure0.94Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure0.82Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure0.80Diluted EPS, Q4 FY2025, three months to 2025-12-31$0.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure0.82Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure0.84Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure
Basic EPS$ per share1.08Basic EPS, Q3 FY2023, three months to 2023-09-30$1.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001811884-24-000022.Report this figurenot reported1.09Basic EPS, Q1 FY2024, three months to 2024-03-31$1.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure0.98Basic EPS, Q2 FY2024, three months to 2024-06-30$0.98 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001096906-25-001281.Report this figure1.02Basic EPS, Q3 FY2024, three months to 2024-09-30$1.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figurenot reported0.92Basic EPS, Q1 FY2025, three months to 2025-03-31$0.92 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure0.94Basic EPS, Q2 FY2025, three months to 2025-06-30$0.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure0.82Basic EPS, Q3 FY2025, three months to 2025-09-30$0.82 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figurenot reported0.82Basic EPS, Q1 FY2026, three months to 2026-03-31$0.82 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure0.84Basic EPS, Q2 FY2026, three months to 2026-06-30$0.84 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure

Balance sheet

Cash and equivalents$87.5m, Q2 FY2026
Long-term debt$0, FY2025
Shareholders' equity$122.0m, Q2 FY2026
Utah Medical Products Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m88.2Cash and equivalents, Q3 FY2023, at 2023-09-30$88.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001811884-23-000021.Report this figure92.9Cash and equivalents, FY2023, at 2023-12-31$92.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-26, accession 0001096906-25-000308.Report this figure93.8Cash and equivalents, Q1 FY2024, at 2024-03-31$93.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-10, accession 0001811884-24-000015.Report this figure89.2Cash and equivalents, Q2 FY2024, at 2024-06-30$89.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-09, accession 0001811884-24-000018.Report this figure88.5Cash and equivalents, Q3 FY2024, at 2024-09-30$88.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001811884-24-000022.Report this figure83.0Cash and equivalents, FY2024, at 2024-12-31$83.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure83.3Cash and equivalents, Q1 FY2025, at 2025-03-31$83.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure82.2Cash and equivalents, Q2 FY2025, at 2025-06-30$82.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001096906-25-001281.Report this figure84.3Cash and equivalents, Q3 FY2025, at 2025-09-30$84.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figure85.8Cash and equivalents, FY2025, at 2025-12-31$85.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure87.4Cash and equivalents, Q1 FY2026, at 2026-03-31$87.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure87.5Cash and equivalents, Q2 FY2026, at 2026-06-30$87.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure
Current assets$m102Current assets, Q3 FY2023, at 2023-09-30$101.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001811884-23-000021.Report this figure106Current assets, FY2023, at 2023-12-31$106.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-26, accession 0001096906-25-000308.Report this figure107Current assets, Q1 FY2024, at 2024-03-31$107.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-10, accession 0001811884-24-000015.Report this figure102Current assets, Q2 FY2024, at 2024-06-30$102.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-09, accession 0001811884-24-000018.Report this figure102Current assets, Q3 FY2024, at 2024-09-30$101.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001811884-24-000022.Report this figure96.3Current assets, FY2024, at 2024-12-31$96.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure96.4Current assets, Q1 FY2025, at 2025-03-31$96.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure94.4Current assets, Q2 FY2025, at 2025-06-30$94.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001096906-25-001281.Report this figure96.5Current assets, Q3 FY2025, at 2025-09-30$96.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figure97.7Current assets, FY2025, at 2025-12-31$97.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure100Current assets, Q1 FY2026, at 2026-03-31$100.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure101Current assets, Q2 FY2026, at 2026-06-30$100.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure
Total assets$m131Total assets, Q3 FY2023, at 2023-09-30$131.2m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001811884-23-000021.Report this figure135Total assets, FY2023, at 2023-12-31$135.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-26, accession 0001096906-25-000308.Report this figure135Total assets, Q1 FY2024, at 2024-03-31$135.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-10, accession 0001811884-24-000015.Report this figure130Total assets, Q2 FY2024, at 2024-06-30$130.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0001811884-24-000018.Report this figure130Total assets, Q3 FY2024, at 2024-09-30$129.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001811884-24-000022.Report this figure123Total assets, FY2024, at 2024-12-31$122.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure123Total assets, Q1 FY2025, at 2025-03-31$122.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure121Total assets, Q2 FY2025, at 2025-06-30$120.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001096906-25-001281.Report this figure122Total assets, Q3 FY2025, at 2025-09-30$122.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figure123Total assets, FY2025, at 2025-12-31$122.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure124Total assets, Q1 FY2026, at 2026-03-31$124.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure125Total assets, Q2 FY2026, at 2026-06-30$124.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure
Current liabilities$m4.2Current liabilities, Q3 FY2023, at 2023-09-30$4.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001811884-23-000021.Report this figure4.7Current liabilities, FY2023, at 2023-12-31$4.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-26, accession 0001096906-25-000308.Report this figure5.5Current liabilities, Q1 FY2024, at 2024-03-31$5.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-10, accession 0001811884-24-000015.Report this figure3.9Current liabilities, Q2 FY2024, at 2024-06-30$3.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-09, accession 0001811884-24-000018.Report this figure3.4Current liabilities, Q3 FY2024, at 2024-09-30$3.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001811884-24-000022.Report this figure3.8Current liabilities, FY2024, at 2024-12-31$3.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure4.3Current liabilities, Q1 FY2025, at 2025-03-31$4.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure2.3Current liabilities, Q2 FY2025, at 2025-06-30$2.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001096906-25-001281.Report this figure3.0Current liabilities, Q3 FY2025, at 2025-09-30$3.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figure2.6Current liabilities, FY2025, at 2025-12-31$2.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure3.5Current liabilities, Q1 FY2026, at 2026-03-31$3.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure2.1Current liabilities, Q2 FY2026, at 2026-06-30$2.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure
Total liabilities$m7.5Total liabilities, Q3 FY2023, at 2023-09-30$7.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001811884-23-000021.Report this figure7.1Total liabilities, FY2023, at 2023-12-31$7.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-26, accession 0001096906-25-000308.Report this figure7.7Total liabilities, Q1 FY2024, at 2024-03-31$7.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-10, accession 0001811884-24-000015.Report this figure6.0Total liabilities, Q2 FY2024, at 2024-06-30$6.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-09, accession 0001811884-24-000018.Report this figure5.5Total liabilities, Q3 FY2024, at 2024-09-30$5.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001811884-24-000022.Report this figure5.1Total liabilities, FY2024, at 2024-12-31$5.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure5.5Total liabilities, Q1 FY2025, at 2025-03-31$5.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure3.3Total liabilities, Q2 FY2025, at 2025-06-30$3.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001096906-25-001281.Report this figure3.7Total liabilities, Q3 FY2025, at 2025-09-30$3.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figure3.3Total liabilities, FY2025, at 2025-12-31$3.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure4.0Total liabilities, Q1 FY2026, at 2026-03-31$4.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure2.5Total liabilities, Q2 FY2026, at 2026-06-30$2.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure
Long-term debt$mnot reported0.0Long-term debt, FY2023, at 2023-12-31$0. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-03-26, accession 0001096906-25-000308.Report this figurenot reportednot reportednot reported0.0Long-term debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figurenot reportednot reportednot reported0.0Long-term debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figurenot reportednot reported
Shareholders' equity$m124Shareholders' equity, Q3 FY2023, at 2023-09-30$123.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-13, accession 0001811884-23-000021.Report this figure128Shareholders' equity, FY2023, at 2023-12-31$128.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-26, accession 0001096906-25-000308.Report this figure128Shareholders' equity, Q1 FY2024, at 2024-03-31$127.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-10, accession 0001811884-24-000015.Report this figure124Shareholders' equity, Q2 FY2024, at 2024-06-30$124.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-09, accession 0001811884-24-000018.Report this figure124Shareholders' equity, Q3 FY2024, at 2024-09-30$124.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001811884-24-000022.Report this figure117Shareholders' equity, FY2024, at 2024-12-31$117.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-27, accession 0001096906-26-000395.Report this figure117Shareholders' equity, Q1 FY2025, at 2025-03-31$117.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure118Shareholders' equity, Q2 FY2025, at 2025-06-30$117.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0001096906-25-001281.Report this figure118Shareholders' equity, Q3 FY2025, at 2025-09-30$118.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figure119Shareholders' equity, FY2025, at 2025-12-31$119.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure120Shareholders' equity, Q1 FY2026, at 2026-03-31$120.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure122Shareholders' equity, Q2 FY2026, at 2026-06-30$122.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure

Cash flow

Operating cash flow$1.4m, Q2 FY2026
Capital expenditure$134.0k, Q2 FY2026
Share repurchases$78.0k, Q2 FY2026
Utah Medical Products Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k5,121Operating cash flow, Q3 FY2023, three months to 2023-09-30$5.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001811884-24-000022. Derived: 9-month figure less the 6-month figure.Report this figure5,332Operating cash flow, Q4 FY2023, three months to 2023-12-31$5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure5,276Operating cash flow, Q1 FY2024, three months to 2024-03-31$5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure2,762Operating cash flow, Q2 FY2024, three months to 2024-06-30$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001096906-25-001281. Derived: 6-month figure less the 3-month figure.Report this figure3,856Operating cash flow, Q3 FY2024, three months to 2024-09-30$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001096906-25-001839. Derived: 9-month figure less the 6-month figure.Report this figure2,937Operating cash flow, Q4 FY2024, three months to 2024-12-31$2.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure4,464Operating cash flow, Q1 FY2025, three months to 2025-03-31$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure2,873Operating cash flow, Q2 FY2025, three months to 2025-06-30$2.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001096906-26-001210. Derived: 6-month figure less the 3-month figure.Report this figure3,878Operating cash flow, Q3 FY2025, three months to 2025-09-30$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001096906-25-001839. Derived: 9-month figure less the 6-month figure.Report this figure3,477Operating cash flow, Q4 FY2025, three months to 2025-12-31$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure3,109Operating cash flow, Q1 FY2026, three months to 2026-03-31$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure1,383Operating cash flow, Q2 FY2026, three months to 2026-06-30$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001096906-26-001210. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k186Capital expenditure, Q3 FY2023, three months to 2023-09-30$186.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001811884-24-000022. Derived: 9-month figure less the 6-month figure.Report this figure90.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$90.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure22.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$22.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure110Capital expenditure, Q2 FY2024, three months to 2024-06-30$110.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001096906-25-001281. Derived: 6-month figure less the 3-month figure.Report this figure89.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$89.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001096906-25-001839. Derived: 9-month figure less the 6-month figure.Report this figure9.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$9.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure184Capital expenditure, Q1 FY2025, three months to 2025-03-31$184.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure51.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$51.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001096906-26-001210. Derived: 6-month figure less the 3-month figure.Report this figure27.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$27.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001096906-25-001839. Derived: 9-month figure less the 6-month figure.Report this figure109Capital expenditure, Q4 FY2025, three months to 2025-12-31$109.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure130Capital expenditure, Q1 FY2026, three months to 2026-03-31$130.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure134Capital expenditure, Q2 FY2026, three months to 2026-06-30$134.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001096906-26-001210. Derived: 6-month figure less the 3-month figure.Report this figure
Dividends paid$k1,071Dividends paid, Q3 FY2023, three months to 2023-09-30$1.1m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2024-11-12, accession 0001811884-24-000022. Derived: 9-month figure less the 6-month figure.Report this figure1,071Dividends paid, Q4 FY2023, three months to 2023-12-31$1.1m. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure1,089Dividends paid, Q1 FY2024, three months to 2024-03-31$1.1m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure1,081Dividends paid, Q2 FY2024, three months to 2024-06-30$1.1m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-08-12, accession 0001096906-25-001281. Derived: 6-month figure less the 3-month figure.Report this figure1,052Dividends paid, Q3 FY2024, three months to 2024-09-30$1.1m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-11-14, accession 0001096906-25-001839. Derived: 9-month figure less the 6-month figure.Report this figure1,038Dividends paid, Q4 FY2024, three months to 2024-12-31$1.0m. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure1,017Dividends paid, Q1 FY2025, three months to 2025-03-31$1.0m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure1,001Dividends paid, Q2 FY2025, three months to 2025-06-30$1.0m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-08-12, accession 0001096906-26-001210. Derived: 6-month figure less the 3-month figure.Report this figure988Dividends paid, Q3 FY2025, three months to 2025-09-30$988.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-11-14, accession 0001096906-25-001839. Derived: 9-month figure less the 6-month figure.Report this figure977Dividends paid, Q4 FY2025, three months to 2025-12-31$977.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure989Dividends paid, Q1 FY2026, three months to 2026-03-31$989.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure987Dividends paid, Q2 FY2026, three months to 2026-06-30$987.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-08-12, accession 0001096906-26-001210. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$k0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-12, accession 0001811884-24-000022. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure2,990Share repurchases, Q1 FY2024, three months to 2024-03-31$3.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure6,403Share repurchases, Q2 FY2024, three months to 2024-06-30$6.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-12, accession 0001096906-25-001281. Derived: 6-month figure less the 3-month figure.Report this figure3,866Share repurchases, Q3 FY2024, three months to 2024-09-30$3.9m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-14, accession 0001096906-25-001839. Derived: 9-month figure less the 6-month figure.Report this figure6,709Share repurchases, Q4 FY2024, three months to 2024-12-31$6.7m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure3,221Share repurchases, Q1 FY2025, three months to 2025-03-31$3.2m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure3,487Share repurchases, Q2 FY2025, three months to 2025-06-30$3.5m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-12, accession 0001096906-26-001210. Derived: 6-month figure less the 3-month figure.Report this figure653Share repurchases, Q3 FY2025, three months to 2025-09-30$653.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-14, accession 0001096906-25-001839. Derived: 9-month figure less the 6-month figure.Report this figure994Share repurchases, Q4 FY2025, three months to 2025-12-31$994.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-27, accession 0001096906-26-000395. Derived: 12-month figure less the 9-month figure.Report this figure128Share repurchases, Q1 FY2026, three months to 2026-03-31$128.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure78.0Share repurchases, Q2 FY2026, three months to 2026-06-30$78.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-12, accession 0001096906-26-001210. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)3.18m, Q2 FY2026
Utah Medical Products Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)k shares3,634Diluted shares (weighted), Q3 FY2022, three months to 2022-09-303,634,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001811884-23-000021.Report this figure3,636Diluted shares (weighted), Q1 FY2023, three months to 2023-03-313,636,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-10, accession 0001811884-24-000015.Report this figure3,639Diluted shares (weighted), Q2 FY2023, three months to 2023-06-303,639,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-09, accession 0001811884-24-000018.Report this figure3,639Diluted shares (weighted), Q3 FY2023, three months to 2023-09-303,639,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001811884-24-000022.Report this figure3,618Diluted shares (weighted), Q1 FY2024, three months to 2024-03-313,618,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001096906-25-000816.Report this figure3,532Diluted shares (weighted), Q2 FY2024, three months to 2024-06-303,532,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001096906-25-001281.Report this figure3,478Diluted shares (weighted), Q3 FY2024, three months to 2024-09-303,478,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figure3,310Diluted shares (weighted), Q1 FY2025, three months to 2025-03-313,310,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure3,246Diluted shares (weighted), Q2 FY2025, three months to 2025-06-303,246,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure3,207Diluted shares (weighted), Q3 FY2025, three months to 2025-09-303,207,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001096906-25-001839.Report this figure3,185Diluted shares (weighted), Q1 FY2026, three months to 2026-03-313,185,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001096906-26-000767.Report this figure3,184Diluted shares (weighted), Q2 FY2026, three months to 2026-06-303,184,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure

Shares outstanding: 3.18mShares outstanding, period not labelled, at 2026-08-113,183,818 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001096906-26-001210.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. Listed shows no prices and gives no investment advice.